These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3627177)

  • 1. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
    N Engl J Med; 1987 Sep; 317(11):707-9. PubMed ID: 3627177
    [No Abstract]   [Full Text] [Related]  

  • 2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
    Blayney DW; Longo DL; Young RC; Greene MH; Hubbard SM; Postal MG; Duffey PL; DeVita VT
    N Engl J Med; 1987 Mar; 316(12):710-4. PubMed ID: 3821809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia following Hodgkin's disease.
    Kaldor JM; Day NE; Clarke EA; Van Leeuwen FE; Henry-Amar M; Fiorentino MV; Bell J; Pedersen D; Band P; Assouline D
    N Engl J Med; 1990 Jan; 322(1):7-13. PubMed ID: 2403650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute leukemia after the treatment of Hodgkin's disease.
    Henry-Amar M; Dietrich PY
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):369-87. PubMed ID: 8468271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute non-lymphoblastic leukosis as a second neoplasm in Hodgkin's disease].
    Díaz Pérez MA; Zamora Auñón P; Escobar Alvarez Y; García de Parecdes ML
    Med Clin (Barc); 1985 Feb; 84(4):167. PubMed ID: 3982119
    [No Abstract]   [Full Text] [Related]  

  • 8. Second primary cancers following treatment of Hodgkin's disease.
    Boivin JF; Hutchison GB; Lyden M; Godbold J; Chorosh J; Schottenfeld D
    J Natl Cancer Inst; 1984 Feb; 72(2):233-41. PubMed ID: 6420598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease, splenectomy and secondary leukemia.
    Centurioni R; Brianzoni F; Leoni P; Danieli G
    Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
    [No Abstract]   [Full Text] [Related]  

  • 10. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
    Henry-Amar M
    J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of long-term side effects--in particular induced leukemias following treatment for Hodgkin's disease.
    De Renzis C; Cellini N; Ausili Cefaro GP; Mantini G; Parisi S; Smaniotto D
    Rays; 1986; 11(2):109-13. PubMed ID: 3602444
    [No Abstract]   [Full Text] [Related]  

  • 13. Hodgkin's disease: controversies and challenges for the future.
    Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani PL
    Haematologica; 1991; 76(4):263-79. PubMed ID: 1724436
    [No Abstract]   [Full Text] [Related]  

  • 14. [Second tumors in patients treated for Hodgkin's disease].
    España P; Bonilla F; Yebra M; Diego J; Alvarez de Mon M; Marazuela M; Durántez A
    Rev Clin Esp; 1988 Apr; 182(6):304-6. PubMed ID: 3406475
    [No Abstract]   [Full Text] [Related]  

  • 15. Hodgkin's disease in children.
    Pao WJ; Kun LE
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):345-65. PubMed ID: 2663832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkitt leukaemia following chemoradiotherapy in a patient with Hodgkin's disease.
    Brenner B; Nagler A; Ben-Arieh Y; Steiner M
    Clin Lab Haematol; 1986; 8(2):163-4. PubMed ID: 3731730
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute myeloid leukemia after treatment of Hodgkin's disease].
    Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease and acute leukemia. Is it a true association?
    Avilés A; Díaz-Maqueo JC; Ayala JR; Cortés HD; García EL
    Arch Med Res; 1992; 23(1):65-8. PubMed ID: 1308794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease.
    Pedersen-Bjergaard J; Larsen SO
    N Engl J Med; 1982 Oct; 307(16):965-71. PubMed ID: 7110299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.